However, while the effectiveness of this adaptive resistance mechanism may be limited, the induction of PD-L1 remains an indicator of strong antitumor immunity within the tumor (infiltrating lymphocytes producing cytokines in response to tumor-specific or tumor-selective antigens). Here, CD274 is linked to neoplasm.